Background: Hepatitis B causes more than 800 000 deaths globally each year. Perinatal infections are a major driver of this burden but can be prevented by vaccination within 24 h of birth.
This book chapter addresses SDG 3 and 5 by explaining that there are substantial differences between female and male patients in physiology, pathology triggering factors, disease progression, clinical approaches and treatment outcome, providing a comprehensive examination and investigation into all aspects of sex differences in cardiac electrophysiology.
This book chapter addresses SDG goals 3 and 5 by explaining how patients' and physicians' education and recruitment strategies can improve to bolster women's enrollment in clinical trials.
The sixth RELX SDG Inspiration Day took place on Wednesday 24 June 2020 with nearly 400 representatives from business, NGOs, academia and civil society. The Inspiration Day gave hope that, although the pandemic has created significant barriers to meeting the SDGs by 2030, global collaboration is our best bet for overcoming them.
This chapter supports SDG 3 by looking at how artificial intelligence (AI) can provide substantial improvements in all areas of healthcare from diagnostics to treatment.
Elsevier,
Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease (Sixth Edition), Volume 1, 2020, Pages 283-297
This chapter addresses Goal 3 by discussing the genetic relationship between Alzheimer's disease and Down Syndrome.
The SDG Impact of COVID-19 podcast series gathers expert opinion exploring the impact of COVID-19 on the Sustainable Development Goals. In this segment, we get the view of Jo Youle, CEO of Missing People.
The SDG Impact of COVID-19 podcast series gathers expert opinion exploring the impact of COVID-19 on the Sustainable Development Goals. In this segment, we get the view of Sandra Kerr, Director of Race Equality at Business in the Community.
Neurodegenerative diseases (NDD) such as Alzheimer's (AD) and Parkinson's disease (PD) are distinct clinical entities; however, the aggregation of key neuronal proteins, presumably leading to neuronal demise appears to represent a common mechanism. It has become evident that advanced glycation end products (AGEs) trigger the accumulation of such modified proteins, which eventually contributes to the pathological aspect of NDDs. Increased levels of AGEs are found in amyloid plaques in AD brains and in both advanced and early PD (incidental Lewy body disease). The molecular mechanisms by which AGE dependent modifications may modulate the susceptibility towards NDDs, however, remain enigmatic and it is unclear whether AGEs may serve as biomarker of NDD. This study detected differential associations between NDD, sex and oxidative stress markers.
This book chapter advances SDGs 3 and 10 by explaining how individuals with diabetes who are of lower socioeconomic status are more likely to have poorer diabetes-related outcomes. Digital health advancements provide unique opportunities to reduce health inequities for this high-risk group.
